Cite

HARVARD Citation

    August, A. et al. (2022). Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults. Open forum infectious diseases. p. . [Online]. 
  
Back to record